{"id":956762,"date":"2026-04-30T16:04:03","date_gmt":"2026-04-30T20:04:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mdxhealth-to-release-first-quarter-2026-financial-results-on-may-13\/"},"modified":"2026-04-30T16:04:03","modified_gmt":"2026-04-30T20:04:03","slug":"mdxhealth-to-release-first-quarter-2026-financial-results-on-may-13","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mdxhealth-to-release-first-quarter-2026-financial-results-on-may-13\/","title":{"rendered":"Mdxhealth to Release First Quarter 2026 Financial Results on May 13"},"content":{"rendered":"
\n

\n Mdxhealth to Release First Quarter 2026 Financial Results on May 13<\/b>\n <\/p>\n

\n
\n Company to Host Conference Call with Live Q&A, May 13, 2026, at 4:30pm ET \/ 22:30 CET<\/i>
\n <\/b>\n <\/p>\n

\n IRVINE, California <\/b>\u2013 April 30, 2026 (GlobeNewswire<\/a>) \u2013 Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the first quarter ended March 31, 2026, after market close on Wednesday, May 13, 2026.<\/p>\n\n\n\n\n\n\n\n
\n Title:<\/b><\/p>\n<\/td>\nMdxhealth Presents First Quarter 2026 Financial Results and
Corporate Update Conference Call and Webcast<\/td>\n<\/tr>\n
\n Date:<\/b>\n <\/td>\nMay 13, 2026<\/td>\n<\/tr>\n
\n Time:<\/b>\n <\/td>\n4:30pm ET\/ 22:30 CET<\/td>\n<\/tr>\n
\n Conference Call D<\/b>
\n ial-in <\/b>
\n Details:<\/b>\n <\/td>\n		\n

United States<\/b>: 1-800-245-3047
Belgium<\/b>: 0800 72 519
United Kingdom<\/b>: 0808 101 1183<\/p>\n<\/td>\n<\/tr>\n

\n Conference ID:<\/b>\n <\/td>\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MDX1Q26<\/td>\n<\/tr>\n
\n Webcast:<\/b>\n <\/td>\n\n https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1758088&tp_key=21da6e9d38<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company\u2019s website.<\/p>\n

\n About Mdxhealth<\/b>\n <\/p>\n

Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company\u2019s tests, based on proprietary genomic, epigenomic, exosomal and other molecular technologies, assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases. For more information, visit mdxhealth.com and follow us on social media at: twitter.com\/mdxhealth, facebook.com\/mdxhealth and linkedin.com\/company\/mdxhealth.<\/p>\n

\n For more information: <\/b>\n <\/p>\n

\n info@mdxhealth.com<\/a>\n <\/p>\n

\n LifeSci Advisors (IR & PR)<\/b>
\n
John Fraunces, Managing Director
Tel: +1 917 355 2395
jfraunces@lifesciadvisors.com<\/a><\/p>\n

\n Attachment<\/strong>\n <\/p>\n